A thematic analysis of the strengths and weaknesses of manufacturers' submissions to the NICE Single Technology Assessment (STA) process

Carroll, C., Kaltenthaler, E., FitzGerald, P., Boland, A. and Dickson, R. (2011) A thematic analysis of the strengths and weaknesses of manufacturers' submissions to the NICE Single Technology Assessment (STA) process. Health Policy, 102 (2-3). pp. 136-144. ISSN 0168-8510

Abstract

Metadata

Authors/Creators:
  • Carroll, C.
  • Kaltenthaler, E.
  • FitzGerald, P.
  • Boland, A.
  • Dickson, R.
Copyright, Publisher and Additional Information: © 2011 Elsevier. This is an author produced version of a paper subsequently published in Health Policy. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: Review; Systematic; Cost effectiveness; Cost benefit analysis; Pharmaceutical industry; Drug approval
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield)
Depositing User: Miss Anthea Tucker
Date Deposited: 09 Nov 2011 16:02
Last Modified: 08 Feb 2013 17:35
Published Version: http://dx.doi.org/10.1016/j.healthpol.2011.06.002 ...
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: 10.1016/j.healthpol.2011.06.002

Download

Filename: WRRO_43420.pdf

Share / Export

Statistics